American Oncology Network Stock Price Patterns

AONC Stock   12.00  0.50  4.35%   
At the present time, The relative strength index (RSI) of American Oncology's share price is at 50. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling American Oncology, making its price go up or down.

Momentum 50

 Impartial

 
Oversold
 
Overbought
The successful prediction of American Oncology's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with American Oncology Network, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting American Oncology's stock price prediction:
Quarterly Revenue Growth
0.514
Using American Oncology hype-based prediction, you can estimate the value of American Oncology Network from the perspective of American Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in American Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying American because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

American Oncology after-hype prediction price

    
  USD 12.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out American Oncology Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.448.8826.19
Details

American Oncology After-Hype Price Density Analysis

As far as predicting the price of American Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in American Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of American Oncology, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

American Oncology Estimiated After-Hype Price Volatility

In the context of predicting American Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on American Oncology's historical news coverage. American Oncology's after-hype downside and upside margins for the prediction period are 0.60 and 29.31, respectively. We have considered American Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
12.00
12.00
After-hype Price
29.31
Upside
American Oncology is very risky at this time. Analysis and calculation of next after-hype price of American Oncology Network is based on 3 months time horizon.

American Oncology Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as American Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading American Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with American Oncology, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.12 
17.31
 0.00  
 0.00  
4 Events / Month
0 Events / Month
In about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
12.00
12.00
0.00 
0.00  
Notes

American Oncology Hype Timeline

American Oncology Network is presently traded for 12.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. American is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is presently at 1.12%. %. The volatility of related hype on American Oncology is about 0.0%, with the expected price after the next announcement by competition of 12.00. About 78.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.89. American Oncology Network had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 4 days.
Check out American Oncology Basic Forecasting Models to cross-verify your projections.

American Oncology Related Hype Analysis

Having access to credible news sources related to American Oncology's direct competition is more important than ever and may enhance your ability to predict American Oncology's future price movements. Getting to know how American Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how American Oncology may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ORPEFOrpea SA 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
EVGRFChina Evergrande New 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
TRGNFTransgene SA 0.00 0 per month 0.00  0.1  0.00  0.00  61.69 
DMTRF3 D Matrix 0.00 0 per month 0.00  0.16  0.00  0.00  27.33 
MAYNFMayne Pharma Group 0.00 0 per month 0.00 (0.16) 4.98 (9.75) 46.83 
HNSBFHansa Biopharma AB 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SLNCFSilence Therapeutics plc 0.00 0 per month 0.00  0.04  11.11  0.00  58.78 
MKLNFM1 Kliniken AG 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
BHCCFBenchmark Holdings plc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
MFCSFMedical Facilities 0.00 0 per month 0.78  0.12  3.25 (1.65) 10.55 

American Oncology Additional Predictive Modules

Most predictive techniques to examine American price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for American using various technical indicators. When you analyze American charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About American Oncology Predictive Indicators

The successful prediction of American Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as American Oncology Network, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of American Oncology based on analysis of American Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to American Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to American Oncology's related companies.
 2023 2024 2025 2026 (projected)
Payables Turnover9.379.628.657.64
Days Of Inventory On Hand13.613.515.5214.93

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Complementary Tools for American Stock analysis

When running American Oncology's price analysis, check to measure American Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy American Oncology is operating at the current time. Most of American Oncology's value examination focuses on studying past and present price action to predict the probability of American Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move American Oncology's price. Additionally, you may evaluate how the addition of American Oncology to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios